Lung cancer in elderly patients;Le cancer bronchique chez le sujet âgé

Revue des Maladies Respiratoires

Volumn 22, Issue 6 C2, 2005, Pages

  Quoix, E ^a   Mennecier, B ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Chemotherapy; Elderly; Lung cancer; Radiotherapy; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL;

BRONCHUS CANCER; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMORBIDITY; GERIATRIC PATIENT; HUMAN; LUNG CANCER; ONCOLOGY; PERFORMANCE; PROGNOSIS; PUBLIC HEALTH; REVIEW; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 33244464494     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1019/200530089     Document Type: Review

References (36)

1. Levi F, La Vecchia CLucchini F, Negri E : Worldwide trends in cancer mortality in the elderly, 1955-1992. Eur J Cancer 1996 ; 32A(4) : 652-72.
2. Firat S, Byhardt RW, Gore E : Co morbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 2002 ; 54 : 357-64.
3. Charlson ME, Pompei P, Ales KL, MacKenzie CR : A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 ; 40 : 373-83.
4. Charlson M, Szatrowski TP, Peterson J, Gold J : Validation of a combined comorbidity index. J Clin Epidemiol 1994 ; 47 : 1245-51.
5. Linn BS, Linn MW, Gurel L : Cumulative illness rating scale. J Am Geriatr Soc 1968 ; 16 : 622-6.
6. Deppermann KM : Influence of age and comorbidities on the chemotherapeutic management of lung cancer. Lung Cancer 2001 ; 33 : S115-20.
7. Balducci L : New paradigms for treating elderly patients with cancer: the comprehensive geriatric assessment and guidelines for supportive care. J Support Oncol 2003 ; 1 : 30-7.
8. Oshita F, Kurata T, Kasai T, Fakuda M, Yamamoto N, Ohe Y, Tamura T, Eguchi K, Shinkai T, Saijo N : Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions. Jpn J Cancer Res 1995 ; 86 : 1198-202.
9. Albain K, Crowley J, Le Blanc M, Livingston RG : Survival determinants in extensive-stage non small cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991 ; 9 : 1618-26.
10. Langer CJ, Manola J, Bernardo P, Kugler JW, Bonomi P, Cella D, Johnson DH : Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 2002 ; 94 : 173-81.
11. Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC : Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol 2001 ; 19 : 1064-70.
12. Lippe P, Silva RR, Giuliodori L, Cancellieri MA, Battelli N, Massacesi C, Berardi R, Bisonni R, Gesuita R, Cellerino R : Advanced non-small cell lung cancer in the elderly: effective and well tolerated weekly gemcitabine and cisplatin regimen. A pilot study. Minerva Med 2000 ; 91 : 53-7.
13. Lilenbaum RC, Herndon JE, 2nd, List MA, Desch C, Watson DM, Miller AA, Graziano SL, Perry MC, Saville W, Chahinian P, Weeks JC, Holland JC, Green MR : Single-Agent Versus Combination Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730). J Clin Oncol 2005 ; 23 : 190-6.
14. Gridelli C : The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study. Oncologist 2001 ; 6 : 4-7.
15. Fidias P, Supko JG, Martins R, Boral A, Carey R, Grossbard M, Shapiro G, Ostler P, Lucca J, Johnson BE, Skarin A, Lynch TJ : A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer. Clin Cancer Res 2001 ; 7 : 3942-9.
16. Quoix E, Breton JL, Ducolone A, Mennecier B, Depierre A, Lemarie E, Moro-Sibilot D, Germa C, Neidhardt AC : First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule. Lung Cancer 2005 ; 47 : 405-12.
17. Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, Piantedosi F, Barbera S, Ferrau F, Piazza E, Rosetti F, Clerici M, Bertetto O, Robbiati SF, Frontini L, Sacco C, Castiglione F, Favaretto A, Novello S, Migliorino MR, Gasparini G, Galetta D, Iaffaioli RV, Gebbia V : Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 2003 ; 95 : 362-72.
18. Frasci G, Lorusso V, Panza N, Comella P, Nicolella G, Bianco A, De Cataldis G, Iannelli A, Bilancia D, Belli M, Massidda B, Piantedosi F, Comella G, De Lena M : Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000 ; 18 : 2529-36.
19. Dajczman E, Fu LY, Small D, Wolkove N, Kreisman H : Treatment of small cell lung carcinoma in the elderly. Cancer 1996 ; 77 : 2032-8.
20. Spiegelman D, Maurer LH, Ware JH, Perry MC, Chahinian AP, Comis R, Eaton W, Zimmer B, Green M : Prognostic factors in small cell carcinoma of the lung: an analysis of 1521 patients. J Clin Oncol 1989 ; 7 : 344-54.
21. Albain K, Crowley J, Le Blanc M, Livingston R : Determinants of improved outcome in small-cell lung cancer: an analysis of the 2580-patients Southwest Oncology Group data base. J Clin Oncol 1990 ; 8 : 1563-74.
22. Siu L, Shepherd F, Murray N, Feld R, Pater J, Zee B : Influence of age on the treatment of limited-stage disease small-cell lung cancer. J Clin Oncol 1996 ; 14 : 421-8.
23. Sagman U, Maki E, Evans WK, Warr D, Shepherd FA, Sculier JP, Haddad R, Payne D, Pringle JF, Yeoh JL, et al. : Small cell lung carcinoma of the lung: derivation of a pronostic stagin system. J Clin Oncol 1991 ; 9 : 1639-49.
24. Lebitasy MP, Hedelin G, Purohit A, Moreau L, Klinzig F, Quoix E : Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994. Br J Cancer 2001 ; 85 : 808-15.
25. Okamoto H, Watanabe K, Nishiwaki Y, Mori K, Kurita Y, Hayashi I, Masutani M, Nakata K, Tsuchiya S, Isobe H, Saijo N : Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer. J Clin Oncol 1999 ; 17 : 3540-5.
26. Quoix E, Breton JL, Daniel C, Jacoulet P, Debieuvre D, Paillot N, Kessler R, Moreau L, Coetmeur D, Lemarie E, Milleron B : Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study. Ann Oncol 2001 ; 12 : 957-62.
27. Westeel V, Murray N, Gelmon K, Shah A, Sheehan F, McKenzie M, Wong F, Morris J, Grafton C, Tsang V, Goddard K, Murphy K, Parsons C, Amy R, Page R : New combination of the old drugs for elderly patients with small cell lung cancer : a pahse II study of the PAVE regimen. J Clin Oncol 1998 ; 16 : 1940-7.
28. Cascinu S, Del Ferro E, Ligi M, Graziano F, Catalano G : The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer. Am J Clin Oncol 1997 ; 20 : 477-8.
29. Foucher P, Coudert B, Arveux P, Boutron MC, Kisterman JP, Bernard A, Faivre J, Jeannin L : Age and prognosis of non-small cell lung cancer. Usefulness of a relative survival model. Eur J Cancer 1993 ; 29A : 1809-13.
30. Epstein SK, Galing LJ, Daly BD, Celli BR : Predicting complications after pulmonary resection. Preoperative exercise testing vs a multifactorial cardiopulmonary risk index. Chest 1993 ; 104 : 694-700.
31. Jaklitsch MT, De Camp MM Jr., Liptay MJ, Harpole DH Jr., Swanson SJ, Mentzer SJ, Sugarbaker DJ : Video-assisted thoracic surgery in the elderly. A review of 307 cases. Chest 1996 ; 110 : 751-8.
32. Pignon T, Gregor A, Schaake Koning C, Roussel A, Van Glabbeke M, Scalliet P : Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 1998 ; 46 : 239-48.
33. Weinmann M, Jeremic B, Toomes H, Friedel G, Bamberg M : Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer. Lung Cancer 2003 ; 39 : 233-53.
34. Jeremic B, Shibamoto Y, Milicic B, Milisavljevic S, Nikolic N, Dagovic A, Aleksandrovic J, Radosavljevic-Asic G : A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 1999 ; 44 : 343-8.
35. Shepherd FA, Amdemichael E, Evans WK, Chalvardjian P, Hogg-Johnson S, Coates R, Paul K : Treatment of small cell lung cancer in the elderly. J Am Geriatr Soc 1994 ; 42 : 64-70.
36. Kurtz ME, Kurtz JC, Stommel M, Givenv CW, Given BA : Symptomatology and loss of physical functioning among geriatric patients with lung cancer. J Pain Symptom Manage 2000 ; 19 : 249-56.